Varenicline emerged as an efficient smoking cessation medication. However, little is known about its association with seizures. Here, we report a case of a young male who suffered a seizure on the day of the last dose of the suggested drug regimen. We argue that the Varenicline seizure was a result of withdrawal rather than a side effect. We therefore discuss several clinical, legal and legislative implications toward the drug prescription and dispensing.